In APDS, these impairments are due to defective, rather than exaggerated, AID expression, leading to elevated serum IgM levels and reduced IgG and IgA levels, which are hallmarks of the disease (35, 36). The gene discussed is AICDA; the disease is activated PI3K-delta syndrome.